Endocrinology, Diabetes & Metabolism

Dr. Anyanate Gwendolyne Jack and Rachel Stahl Salzman Discuss Advancements in Obesity and Diabetes Management

woman jogging

In the latest episode of Weill Cornell Medicine's Back to Health podcast, Dr. Anyanate Gwendolyne Jack and Rachel Stahl Salzman, M.S. discuss what patients should know about recent advancements in obesity and diabetes management. They review risk factors and behaviors that can lead to obesity, as well as address systemic issues that can lead to disparities in diverse communities. They also highlight the multidisciplinary team approach...

Dr. Marcus D. Goncalves Inducted into the American Society for Clinical Investigation (ASCI)

Dr. Marcus D. Goncalves, the Ralph L. Nachman, M.D. Research Scholar and an assistant professor of medicine in the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine, has been elected as a member of the American Society for Clinical Investigation (ASCI) for 2024....

New Study Reveals Promising Findings to Treat Type 2 Diabetes

A new study published in the Journal of Clinical Investigation has demonstrated that activating a pathway to promote cell division not only expanded the population of insulin-producing cells, but, surprisingly, also enhanced the cells’ function. The findings hold promise for future therapeutics that will improve the lives of individuals with type 2 diabetes—a condition that affects more than half a billion people worldwide.“That’s reassuring...

Intercampus Symposium Highlights Metabolic Health Research

A cross-campus symposium brought together nearly 100 researchers from Weill Cornell Medicine and Cornell College of Human Ecology to catalyze the kind of interdisciplinary collaborations necessary to address the complex challenges of treating diabetes, obesity, and metabolic diseases.Titled "Metabolic Health: From Molecules to Populations," the symposium focused on three topics: diabetes at the molecular and cellular level, obesity and the biology of fat cells, and population-level...

Led by Dr. Imperato-McGinley, the CTSC Receives $61.9 Million Grant from NIH (NCATS)

Dr. Julianne Imperato-McGinley
This award is the largest federal grant ever given to Weill Cornell Medicine and represents 20 years of continuous funding for the CTSC under Dr. Imperato-McGinley’s direction.

Annual Quality Improvement and Patient Safety (QIPS) Poster Symposium: Continued Success

2022 QIPS Symposium
The interdepartmental and interdisciplinary celebration of quality and patient safety initiatives included 27 projects from 13 departments across WCM, Lower Manhattan Hospital, NYP/Queens, and NYP/Brooklyn Methodist.

Clinic for Gender Affirming Care Opens in the Weill Department of Medicine

Dr. Ann Danoff
In a welcoming environment, the team is committed to providing individualized gender affirming hormone treatment. When feasible, the team suggests in person appointments for initial visits but will also accommodate patients for virtual visits.

WDOM’s 6th Annual Research Retreat Day Hosts Leader in RNA and Vaccine Research

2021 research retreat
Lectures were provided by WDOM faculty and keynote speaker, Dr. Drew Weissman, who played a major role in critical discoveries that allowed for the mRNA platform to be used in developing vaccines against SARS-CoV.

Dr. Lo and Colleagues Publish Key Findings on COVID-19 and Insulin Resistance

Dr. James C. Lo
The researchers found that SARS-CoV-2 triggers an inflammatory antiviral response in the adipose tissue (body fat) and causes its dysfunction.

The Joan and Sanford I. Weill Center for Metabolic Health Opens: Bringing Together Experts to Catalyze Discovery in Metabolic Disease

Center for Metabolic Health Opening
The new Center is well-positioned to become a world-renowned leader for scientific discovery in translational and molecular discovery related to the pathogenesis and treatment of metabolic disease.